Elsie Biotechnologies

Actionable Insights Powered by AI

GSK Acquires Oligonucleotide Partner Elsie for Up to $50 Million

GSK, Elsie Biotechnologies, oligonucleotide platform, acquisition, biotech, pharmaceuticals